"La clinique de l'Infirmerie Protestante à Lyon assure une prise en charge lourde et complexe, à la fois médicale et chirurgicale. Dans plus de 30 spécialités, les équipes soignantes et l'administration de la clinique sont mobilisées pour offrir aux patients : Une prise en charge personnalisée Un parcours de soins conçu dans son ensemble, incluant une prise en charge en amont et en aval Une prestation de haut niveau sur des plateaux techniques équipés de technologies de pointe : bloc opératoire moderne et performant, salles de cardiologie interventionnelle, salles d'endoscopie L'accès égal pour tous aux soins Des programmes de prévention La meilleure sécurité sanitaire"

During the past decade, Infirmerie Protestante de Lyon conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.9% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 1 clinical trials were completed. i.e. 4.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Infirmerie Protestante de Lyon" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 7 trials, followed by "Centre Leon Berard" with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "ARCAGY/ GINECO GROUP" with 1 trials sponsored and "Assistance Publique - Hôpitaux de Paris" with 1 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Infirmerie Protestante de Lyon" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "AlpinARC" with 1 trials as a collaborator and "Association de Neuro-Oncologues d'Expression Francaise" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Infirmerie Protestante de Lyon" are "Cancer" (3 trials), "Rheumatoid Arthritis" (3 trials), "Arthritis, Rheumatoid" (2 trials), "Breast Cancer" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Infirmerie Protestante de Lyon" in a lesser frequency.

Most popular intervention types in "Infirmerie Protestante de Lyon" are "Drug" (17 trials), "Other" (8 trials), "Device" (4 trials), "Procedure" (4 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "FOLFIRI Protocol" (2 trials), "Oxaliplatin" (2 trials), "Panitumumab" (2 trials) and "5 FU bolus" (1 trials). Other intervention names were less common.

The vast majority of trials in "Infirmerie Protestante de Lyon" are 37 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Infirmerie Protestante de Lyon". undefined are not yet recruiting, 12 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Infirmerie Protestante de Lyon, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Infirmerie Protestante de Lyon, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".

Infirmerie Protestante de Lyon has several departments that took part in Clinical trials: "Infirmerie Protestante; Endos Digestive Coelioscopie" - 2 trials